Delivery Order SPE2DB24D3013-SPE2DB24FFFXT

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,172.80 firm fixed-price delivery order is for VEVYE 0.1% eye drops, with a period of performance through March 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,978.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4567924056 - VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,083.16 fixed-price delivery order is for the supply of a specific pharmaceutical product, VEVYE 0.1% eye drops, with a performance period ending on May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.78 Firm Fixed Price delivery order contract covers the procurement of 4567441115 ! MIEBO 100% EYE DROP 3ML medical supplies. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,707.80 firm fixed-price delivery order (SPE2DX15D1053|SPE2DX25F6LSL) is for the supply of 4567847334 ! VEVYE 0.1% EYE DROP 2ML, with an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,338.59, is for the delivery of a pharmaceutical product called "4567557411 ! VEVYE 0.1% EYE DROP 2ML". The contract is a Firm Fixed Price Delivery Order with a period of performance through March 13, 2025. There is no set-aside designation for this award. The contract is part of a larger...
This federal contract award is a firm fixed price delivery order worth $14,390.05, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the supply of a pharmaceutical product, "VEVYE 0.1% EYE DROP 2ML," with a period of performance through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger indefinite delivery contract (IDC) with DLA valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,105.85 firm fixed-price delivery order is for MIEBO 100% EYE DROP 3ML, a medical product. The contract has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a $2,526.13 Firm Fixed Price delivery order for "MIEBO 100% EYE DROP 3ML" medical supplies. The contract has an ultimate completion date of July 9, 2025 and was awarded on July 8, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, valued at $1,507.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a 0.5% eye drop lubricant product, with a period of performance through November 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFFXT
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,475.29 firm fixed-price delivery order is for the supply of VEVYE 0.1% eye drops, a medical product. The contract has an ultimate completion date of June 21, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 4/4/25, 9:54 AM